Showing 1 - 3 results of 3 for search 'Katherine G Young', query time: 0.03s Refine Results
  1. 1
    Recent UK type 2 diabetes treatment guidance represents a near whole population indication for SGLT2-inhibitor therapy

    Recent UK type 2 diabetes treatment guidance represents a near whole population indication for SGLT2-inhibitor therapy by Katherine G. Young, Rhian Hopkins, Beverley M. Shields, Nicholas J. Thomas, Andrew P. McGovern, John M. Dennis, the MASTERMIND consortium

    Published 2023-11-01
    Get full text
    Article
  2. 2
    Risk factor associations for severe COVID-19, influenza and pneumonia in people with diabetes to inform future pandemic preparations: UK population-based cohort study

    Risk factor associations for severe COVID-19, influenza and pneumonia in people with diabetes to inform future pandemic preparations: UK population-based cohort study by Beverley M Shields, Bilal A Mateen, Andrew P McGovern, John M Dennis, Sebastian J Vollmer, Daniyal Raja, Rhian Hopkins, Katherine G Young, Nicholas J Thomas, James Godwin, Robert J Challen

    Published 2024-01-01
    Get full text
    Article
  3. 3
    Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review

    Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review by Katherine G. Young, Eram Haider McInnes, Robert J. Massey, Anna R. Kahkoska, Scott J. Pilla, Sridharan Raghavan, Maggie A. Stanislawski, Deirdre K. Tobias, Andrew P. McGovern, Adem Y. Dawed, Angus G. Jones, Ewan R. Pearson, John M. Dennis, ADA/EASD PDMI

    Published 2023-10-01
    Get full text
    Article

Search Tools: